What are the diagnostic criteria for hypovolemic shock?

Diagnostic Criteria for Hypovolemic Shock

Hypovolemic shock is diagnosed by the presence of acute circulatory failure with signs of inadequate tissue perfusion (abnormal skin perfusion, decreased urine output, altered mental status), typically accompanied by hypotension and tachycardia, elevated lactate >2 mmol/L, and evidence of significant intravascular volume loss—though hypotension is not mandatory for diagnosis. 1

Core Diagnostic Framework

The 2025 ESICM guidelines establish that shock diagnosis requires a multi-parameter assessment rather than relying on any single variable 1. For hypovolemic shock specifically, you must identify:

1. Clinical Signs of Hypoperfusion (Primary Criteria)

Assess three readily accessible organ systems 1:

• Skin: Abnormal cutaneous perfusion (prolonged capillary refill time >3 seconds, mottling, cool extremities)
• Kidneys: Decreased urine output (oliguria <0.5 mL/kg/hr)
• Brain: Altered mental status (confusion, agitation, obtundation)

2. Hemodynamic Parameters (Supporting Criteria)

• Tachycardia: Typically present as compensatory mechanism
• Hypotension: Commonly present but NOT required for diagnosis 1—this is a critical pitfall to avoid, as patients can be in shock with normal blood pressure due to compensatory mechanisms

3. Laboratory Evidence

• Lactate >2 mmol/L: Reflects cellular dysoxia and inadequate oxygen utilization 1
• Serial lactate measurements should be performed to monitor progression and response 1

4. Underlying Etiology

Document significant intravascular fluid or blood loss from 2:

• Hemorrhage (trauma, GI bleeding, ruptured ectopic pregnancy)
• Fluid losses (vomiting, diarrhea, burns, third-spacing)

Pattern Recognition: Low Flow State

Hypovolemic shock is characterized by a low cardiac output pattern due to critically impaired cardiac preload from volume depletion 1, 3. This distinguishes it from distributive shock (hyperkinetic state) but shares low flow characteristics with cardiogenic and obstructive patterns.

Advanced Monitoring Parameters (When Available)

If central venous and arterial access present 1:

• Central venous oxygen saturation (ScvO₂)
• Veno-arterial CO₂ gradient (PvaCO₂)
• These help assess adequacy of cardiac output and guide therapy

Critical Pitfalls to Avoid

1. Do not wait for hypotension to diagnose shock—tissue hypoperfusion signs precede blood pressure collapse 1
2. Never rely on a single variable for diagnosis or management 1
3. Serial assessments are mandatory—shock is dynamic, requiring repeated evaluation of perfusion markers 1
4. Exclude other shock types: Ensure cardiac dysfunction (cardiogenic), obstruction (PE, tamponade), or vasodilation (septic, anaphylactic) are not primary causes 3, 4

Algorithmic Approach

1. Identify clinical hypoperfusion (skin/kidney/brain assessment)
2. Measure lactate (expect >2 mmol/L)
3. Document hemodynamic instability (tachycardia ± hypotension)
4. Confirm volume loss etiology
5. Exclude alternative shock patterns through clinical context
6. Initiate serial monitoring of perfusion markers

The diagnosis is fundamentally clinical and physiologic, not dependent on arbitrary blood pressure cutoffs 1. Early recognition before hemodynamic collapse is essential to prevent progression to irreversible organ dysfunction and death 2, 5.